{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-024862","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.459520+00:00","generated_at":"2026-05-17T20:27:51.113619+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Vascular Q2 sales up 15% to $64.2M; raises FY guidance","bullets":["Q2 EPS $0.60 (+16% YoY); sales $64.2M (+15% organic) driven by catheters (+27%) and grafts (+19%).","Gross margin 70.0% (+110 bps); operating income $16.1M (+12%).","Full-year guidance raised: sales $248-$254M (midpoint +14%), EPS $2.23-$2.37 (midpoint +19%).","Quarterly dividend of $0.20/share declared, payable Sept 4, 2025 to holders of record Aug 21.","Cash increased $16.9M sequentially to $319.5M; $75M share repurchase program active through Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-024862","json":"https://secwatch.observer/filing/0001437749-25-024862.json","markdown":"https://secwatch.observer/filing/0001437749-25-024862.md","text":"https://secwatch.observer/filing/0001437749-25-024862.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/0001437749-25-024862-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/lmat20250805_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:27:51.113619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}